chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Debilitating anxiety; I am the point now where I cant even work because I have the debilitating anxiety; I was healthy before this; Adrenal flushes and stuff like that but it is debilitating; I can barely do anything anymore because of this; anxiety and depression out of nowhere; I started getting these ''flashes'', like adrenaline ''dumps''; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 49 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Sep2021 (Lot number: 301458A) at the age of 48 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: ANXIETY (non-serious) with onset 2021, outcome "unknown", described as "Debilitating anxiety; I am the point now where I cant even work because I have the debilitating anxiety; I was healthy before this"; ADRENAL DISORDER (non-serious) with onset 2021, outcome "unknown", described as "Adrenal flushes and stuff like that but it is debilitating; I can barely do anything anymore because of this"; DEPRESSION (non-serious) with onset 2021, outcome "unknown", described as "anxiety and depression out of nowhere"; HOT FLUSH (non-serious) with onset 2021, outcome "unknown", described as "I started getting these ''flashes'', like adrenaline ''dumps''".  No follow-up attempts are possible. No further information is expected.
couldn't receive my 2nd dose 1 month apart as recommended; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jun-2021 and was forwarded to Moderna on 23-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (couldn't receive my 2nd dose 1 month apart as recommended) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (couldn't receive my 2nd dose 1 month apart as recommended). At the time of the report, PRODUCT DOSE OMISSION ISSUE (couldn't receive my 2nd dose 1 month apart as recommended) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.  No treatment medication were reported.
. I had some symptoms (event captured as per verbatim since further clarification was unknown) but not that like fever going above 100 degree Fahrenheit; This is a spontaneous report from a contactable consumer (Patient). This is the second case out of two cases in which the female consumer reported for herself.  A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EW0176; Expiration Date: Aug2021) via an unspecified route of administration, on an unspecified date, as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pyrexia. The patient stated that she and her husband both got the Covid vaccine, Pfizer one. On an unspecified date, the patient had some symptoms (event captured as per verbatim since further clarification was unknown) but not that like fever going above 100 degree Fahrenheit. The patient underwent lab tests and procedures which included body temperature: not that like fever going above 100 degree Fahrenheit, on an unspecified date. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
-Headache -Dizziness -Extreme tiredness, Weakness -Arm pain -Paleness -Fast hart beat
Blood clot; Unable to use arm at all; This is a spontaneous report from a contactable consumer (patient, self-reported). A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, in arm left, on 09Mar2021 02:15 AM, as single dose for COVID-19 immunization. Patient's medical history included Fibromyalgia. Concomitant medications were not reported. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. Patient did not receive other vaccine in four weeks of vaccination. On an unknown date in Mar2021, patient had Blood clot and patient was unable to use arm at all. Patient resulted in Emergency room/department or urgent care, Disability or permanent damage in Mar2021. Patient did not receive treatment for adverse events. Seriousness of the events reported as hospitalization and disability. Outcome of the events was not recovered.  Information about lot/batch number has been requested.
itching,felt itchy,itching like crazy; has hives; down towards her elbow, it has been Hurting Ever since; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching,felt itchy,itching like crazy), VACCINATION SITE URTICARIA (has hives) and ARTHRALGIA (down towards her elbow, it has been Hurting Ever since) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (itching,felt itchy,itching like crazy), VACCINATION SITE URTICARIA (has hives) and ARTHRALGIA (down towards her elbow, it has been Hurting Ever since). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itching,felt itchy,itching like crazy), VACCINATION SITE URTICARIA (has hives) and ARTHRALGIA (down towards her elbow, it has been Hurting Ever since) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported
vesicular rash, which was diagnosed as severe herpes zoster or shingles; The vaccine did not prevent shingles as intended; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age or gender. The patient's medical history, concurrent conditions and concomitant medication use were not provided.   In 2014, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dose, strength, administration route, anatomical location, lot number and expiration date were not reported) for routine adult health maintenance and for the long-term prevention of shingles at a health center.The reporter stated that the vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. Later in 2014, the patient was treated in the health center, for the onset of a vesicular rash, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles. The patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages.
Client complained of felling dizzy after the 15 minutes post vaccination. Client was helped to a flat position, legs were elevated. Client remained alert and oriented x 3, no SOB or chest pain reported. Vital signs were stable. Rested for another 30 minutes, water was given. Client reported feeling better afterwards. She was picked up by her father. We recommended client to call PCP if symptoms persist and call 911 if Symptoms worsen.
No adverse effects were reported; Patients were administered improperly stored vaccines doses; This spontaneous report was received from a registered nurse, concerning a patient of unspecified age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported.   On 11-APR-2019, the patient was vaccinated with improperly storage doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis, lot #R034700 and expiration date 16-JUN-2020 (strength, dose, frequency and route of administration were not reported); with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis, lot #R033080 and expiration date 06-JUN-2020 (strength, dose, frequency and route of administration were not reported); and with hepatitis a vaccine, inactivated (VAQTA) for prophylaxis lot #S001485, expiration date 12-MAY-2020 and lot #R012988 and expiration date 30-MAY-2019. No adverse effects were reported.   The temperature excursion was reported as below 36°F (35.4°F) during a time frame of 27 minutes. Previous temperature excursion was reported as below 36°F (35.4°F) during a time frame of 15 minutes.   A digital data logger was involved.    This is one of several reports received from the same  reporter.; Sender's Comments:  US-009507513-1904USA012221: US-009507513-1905USA002744: US-009507513-1905USA002745: US-009507513-1905USA002746: US-009507513-1905USA002747: US-009507513-1905USA002748: US-009507513-1905USA002749: US-009507513-1905USA002750: US-009507513-1905USA002751: US-009507513-1905USA002752: US-009507513-1905USA002753: US-009507513-1905USA002754: US-009507513-1905USA002755: US-009507513-1905USA002756: US-009507513-1905USA002757: US-009507513-1905USA002758: US-009507513-1905USA002759: US-009507513-1905USA002760: US-009507513-1905USA002761: US-009507513-1905USA002762: US-009507513-1905USA002763: US-009507513-1905USA002764: US-009507513-1905USA002765: US-009507513-1905USA002766: US-009507513-1905USA002767: US-009507513-1905USA002768: US-009507513-1905USA002769:
unable to raise his arm; red spot on his arm; arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (unable to raise his arm), VACCINATION SITE ERYTHEMA (red spot on his arm) and VACCINATION SITE PAIN (arm hurt) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Bone cancer (bone cancer of the clavicle). Concurrent medical conditions included Prostate cancer. Concomitant products included OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced LIMB DISCOMFORT (unable to raise his arm), VACCINATION SITE ERYTHEMA (red spot on his arm) and VACCINATION SITE PAIN (arm hurt). On 25-Mar-2021, LIMB DISCOMFORT (unable to raise his arm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (red spot on his arm) and VACCINATION SITE PAIN (arm hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Contact details updated
Local redness and induration 2.5cm x 1.5cm L thigh.
Pain in left Deltoid radiating down arm, tingling in left hand, pain when arm is extended, loss of strength in left arm, loss of mobility in left arm.
This is a non serious case from a health care professional in the USA involving cough (labeled,USA). The reporter causality is not provided. This case is submitted according to the VAERS Safety Surveillance accelerated reporting agreement for FluMist. A 26 year old female received FluMist in 10/2004. On 01/30/2005, the patient experienced cough, myalgia, and fever. She took the Quidel Flu test and was positive for Influenza A and B. The patient has not yet recovered. Follow up - 27Apr05 additional information received from the reporter: Lot number: 500335P and expiration date: 11May05
Pt. states approx. 10 days after MMR dose (given 9/4/2002)that he developed a slight fever, macular rash to arms, & legs, with a few "spots" noted on torso and neck.  He describes having a headache & malaise which persisted for a couple days.  Today pt. has isolated errythemic spots remaing on lower extremities.  Pt. states he had been scratching these spots more than the others.  Pt. did not disclose symptoms till follow up visit for second dose of MMR vaccine today.  And then only upon questioning did he reveal symptoms.  Discussed with medical director, no treatment needed at the time.
MOTHER CALLED AT 615 PM STATING CHILD HAD FEVER OF 105.2 RECTALLY.  NO OTHER SYMPTOMS. HAD MOTHER RECHECK FEVER 104.8 RECTALLY.
Information has been received from a pharmacist referring to a 48 year old patient of unknown gender. The patient had no  history of chickenpox and history of negative varicella titers. On an unknown date, the patient presented a prescription written simply for varicella vaccine. So based on the patient's age, the pharmacist decided to administer a dose of ZOSTAVAX (dose, route and lot # were unknown) (inappropriate schedule of drug administration). It was then discovered the patient's physician intended for the patient to receive (Oka/Merck) VARIVAX (wrong drug administered). No adverse effect was reported. No product confusion reported. Additional information is not expected as the reporter declined to participate in adverse event collection process.
This case was reported by a consumer and described the occurrence of neck pain in a 50-year-old female  patient who received ENGERIX B. Concomitant products included DTPa (Reduced antigen), Flu Seasonal TIV Dresden (Influenza vaccine unspecified 2014-2015 season), levothyroxine and ENGERIX B. On 12th January 2015, the patient received the 2nd dose of ENGERIX B (unknown). In January 2015, less than a month after receiving ENGERIX B and less than a day after receiving dTpa vaccine and Influenza vaccine unspecified 2014-2015 season, the patient experienced neck pain, pain in arm and local swelling. ENGERIX B was continued with no change. In January 2015, the outcome of the pain in arm was recovered/resolved. On an unknown date, the outcome of the neck pain and local swelling were not recovered/not resolved. It was unknown if the reporter considered the neck pain to be related to ENGERIX B. The reporter considered the pain in arm and local swelling to be related to ENGERIX B. See case US2015023566 for details regarding the events following previous vaccinations. Additional information was provided: She received her second shot of ENGERIX-B on January 12th and besides the normal soreness, the back of her neck again because sore. The patient again felt like all the medicine went straight to the back of her neck. The patient said it feels like a bone at the top of her spine and she cannot stop touching it. She also cannot sit good because of it. It will often get better when she goes to sleep but within hours of waking up it swells back up. She has not done anything to herself or gotten hurt so she is 100% that she is experiencing a rare side effect from ENGERIX-B.
Information has been received from a nurse referring to unknown number of patients of unknown age and gender. No concurrent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (lot# K012457, expiration, expiration date 04-JUN-2017; lot# L004743, expiration date 01-JUN-2017; lot# K005958, expiration date 09-FEB-2017; strength, dose and route unknown). No adverse effects were reported. This is one several reports received from the same reporter. Additional information has been requested.
Approx. 12 hrs after receiving flu shot tongue started "tasting metallic" & swelling. ER visit hoarse/sore throat, received injection of BENADRYL. Today c/o hoarseness & aching. Pt states would like to know what additive/preservative is so she can list as allergy in future - pkg insert given to pt.
Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Nausea-Severe, Systemic: Unable to Sleep-Severe, Additional Details: He was covered in red spots, terrible itching.  Couldn't sleep or eat for 3-4 weeks.  He has taken mostly steroids to treat.  Finally cleared on about May 14th.  He said the itching was intense, could not eat or sleep.   Ready to jump out of his skin.   Just wanted to call someone to let them know and document.
pt became ill w/acute lymphocytic leukemia on 223OCT93 very soon p/receiving a flu shot; relapsed p/receiving school vax; relapse confirmation was 10AUG93; pt exp fever, blood test results indicated many abn cells; exp viral infect;
Information has been received from an unknown age female patient concerning herself. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (dose, lot # and route were not reported). On an unknown date, the patient experienced cold-like symptoms that involved mucus in the back of the throat after receiving ZOSTAVAX. Outcome of the event was unknown. Additional information has been requested.
Slightly red, swollen, warm hot to touch, tenderness, Tylenol every 6 hours.
Severe pain at injection site from 8-24 hours after injection. Body aches, chills, dizziness, fatigue, nausea, loss of appetite until present (117 hours after injection), reduced from severe to moderate within 24 hours, severe again 100-110 hours after injection, mild afterward.
Woke up extreme dizzy 5 days after my first dose. For 2 days straight I was unbalanced, nauseous and felt flushed but did not run a fever or have any pain anywhere except my arm being sore at injection site. It has gotten better, but I still occasionally feel dizzy and sleeping on my right side seems to make it worse in the morning.  I have never felt like this before and do not have a history of vertigo.
No adverse event; The patient received her first primary series of the Moderna Covid-19 monovalent vaccine 10 months ago. The patient has not yet received their second Moderna Covid-19 vaccine primary series dose; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (The patient received her first primary series of the Moderna Covid-19 monovalent vaccine 10 months ago. The patient has not yet received their second Moderna Covid-19 vaccine primary series dose) and NO ADVERSE EVENT (No adverse event) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In November 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (The patient received her first primary series of the Moderna Covid-19 monovalent vaccine 10 months ago. The patient has not yet received their second Moderna Covid-19 vaccine primary series dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (The patient received her first primary series of the Moderna Covid-19 monovalent vaccine 10 months ago. The patient has not yet received their second Moderna Covid-19 vaccine primary series dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (The patient received her first primary series of the Moderna Covid-19 monovalent vaccine 10 months ago. The patient has not yet received their second Moderna Covid-19 vaccine primary series dose).    Concomitant drugs were not reported. It was reported that the patient has not yet received their second Moderna Covid-19 vaccine primary series dose. Treatment medications were not provided.   Reporter did not allow further contact
Red, hot area, 4 in in diameter. Not swollen. Left arm. No pain or tenderness now. Fever up to 102 on day 1 and 2 following shot.
?Covid arm.? Delayed redness/rash/itchiness at the injection site. Occurring 9 days after 1st injection. Lesion is 1-2 inches in width.
I got really dizzy. The next day got achy all over especially in both my legs. Had these symptoms for about 3 days. The dizziness actually lasted a couple of weeks. I also had shortness of breath. Also last week I got a lot of pain in my back from shoulder blades down to my ribs. Like contractions as if I were in labor. Also last week I had soreness from the injection site and the area a little lump. I actually had COVID 19 in December 2019 until the third week in February 2020.  Also I have had a lingering cough since December 2019.
Pt developed a fever of 103F-104F which started 4 hours, post vax, lasting 45 days. No other signs or symptoms. On exam, site was redder that other shots he ever had.
Painful swelling of lymph nodes under arm & into breast tissue; Dizziness; Light-headedness when standing; Booster; Pain at injection site; Painful swelling of lymph nodes under arm & into breast tissue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY), intramuscular, administered in deltoid left, administration date 12Jan2022 16:30 (Lot number: FL3209) at the age of 46 years as dose numner unknown (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer- Unknown, Dose number unknown), for COVID-19 immunization.  The following information was reported: IMMUNISATION (non-serious) with onset 12Jan2022 16:30, outcome "unknown", described as "Booster"; VACCINATION SITE PAIN (non-serious) with onset Jan2022, outcome "unknown", described as "Pain at injection site"; LYMPHADENOPATHY (non-serious) with onset 20Jan2022, outcome "recovered" (24Jan2022), LYMPH NODE PAIN (non-serious) with onset Jan2022, outcome "recovered" (24Jan2022) and all described as "Painful swelling of lymph nodes under arm & into breast tissue"; DIZZINESS (non-serious) with onset 14Jan2022, outcome "recovered" (15Jan2022), described as "Dizziness"; DIZZINESS (non-serious) with onset 14Jan2022, outcome "unknown", described as "Light-headedness when standing". Therapeutic measures were taken as a result of lymphadenopathy, lymph node pain. Therapeutic measures were not taken as a result of dizziness.    Follow-Up (25Jan2022): Follow-up attempts are completed. No further information is expected.
I woke up one morning and felt nauseous and dizzy. I was throwing up every 10-15 minutes. I went to the doctor after a few hours. I was treated for vertigo, nausea. I was unable to keep any medication down because of the vomiting. Enough of the medication took after about an hour to an hour and a half. I was able to sit up on my own without falling over. They did a blood test. I took Meclizine for the dizziness. Within 36 hours after initial symptoms, I was feeling fine. I was taking the Meclizine for 7 days until I was feeling well enough to stop. The blood test run by the doctors showed no signs of illness. This makes me consider that it could've been the vaccine. I have never experienced such dizziness before and I am concerned about this. It is unexplainable.